weight loss
Eli Lilly’s Retatrutide Shows Remarkable Weight Loss Results in Phase 3 Trial
Eli Lilly’s retatrutide has shown significant weight loss in a Phase 3 trial, potentially revolutionizing obesity treatment.
Semaglutide Patent Expiration Sparks Weight Loss Industry Boom
The expiration of semaglutide’s patent signals a transformative era for weight loss treatments, with generics likely to enhance accessibility.